NCT00148083View on ClinicalTrials.gov

Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

Risperdal Consta (drug)

BEHAVIORAL

Social Skills Training

Trial Locations (2)

10605

New York Presbyterian Hospital, White Plains

60612

University of Illinois at Chicago, Chicago

All Listed Sponsors
collaborator

Janssen, LP

INDUSTRY

collaborator

Weill Medical College of Cornell University

OTHER

lead

University of Illinois at Chicago

OTHER

NCT00148083 - Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia | Biotech Hunter | Biotech Hunter